Titre : Sécurité chimique

Sécurité chimique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sécurité chimique : Questions médicales les plus fréquentes", "headline": "Sécurité chimique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sécurité chimique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-09", "dateModified": "2025-05-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sécurité chimique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sécurité", "url": "https://questionsmedicales.fr/mesh/D012449", "about": { "@type": "MedicalCondition", "name": "Sécurité", "code": { "@type": "MedicalCode", "code": "D012449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.135.060.075" } } }, "about": { "@type": "MedicalCondition", "name": "Sécurité chimique", "alternateName": "Chemical Safety", "code": { "@type": "MedicalCode", "code": "D062067", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "E D van Asselt", "url": "https://questionsmedicales.fr/author/E%20D%20van%20Asselt", "affiliation": { "@type": "Organization", "name": "Wageningen Food Safety Research, Wageningen, The Netherlands." } }, { "@type": "Person", "name": "H J van der Fels-Klerx", "url": "https://questionsmedicales.fr/author/H%20J%20van%20der%20Fels-Klerx", "affiliation": { "@type": "Organization", "name": "Wageningen Food Safety Research, Wageningen, The Netherlands." } }, { "@type": "Person", "name": "Ans Punt", "url": "https://questionsmedicales.fr/author/Ans%20Punt", "affiliation": { "@type": "Organization", "name": "Wageningen Food Safety Research, 6700 AE Wageningen, The Netherlands." } }, { "@type": "Person", "name": "Martin F Wilks", "url": "https://questionsmedicales.fr/author/Martin%20F%20Wilks", "affiliation": { "@type": "Organization", "name": "Swiss Centre for Applied Human Toxicology, University of Basel, 4055 Basel, Switzerland." } }, { "@type": "Person", "name": "Paul A Hepburn", "url": "https://questionsmedicales.fr/author/Paul%20A%20Hepburn", "affiliation": { "@type": "Organization", "name": "Unilever, Safety & Environmental Assurance Centre, Colworth Science Park, Sharnbrook MK44 1LQ, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Mediterranean-Diet-Based Nutritional Intervention for Children with Prediabetes in a Rural Town: A Pilot Randomized Controlled Trial.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36079871", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/nu14173614" } }, { "@type": "ScholarlyArticle", "name": "Ultrasound-guided paravertebral blockade reduced perioperative opioids requirement in pancreatic resection: A randomized controlled trial.", "datePublished": "2022-08-30", "url": "https://questionsmedicales.fr/article/36111230", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fsurg.2022.903441" } }, { "@type": "ScholarlyArticle", "name": "Pericapsular nerve group (PENG) block for hip arthroscopy: a randomized, double-blinded, placebo-controlled trial.", "datePublished": "2022-08-23", "url": "https://questionsmedicales.fr/article/35998937", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/rapm-2022-103907" } }, { "@type": "ScholarlyArticle", "name": "A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.", "datePublished": "2022-08-23", "url": "https://questionsmedicales.fr/article/36644237", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jhepr.2022.100563" } }, { "@type": "ScholarlyArticle", "name": "Chopstick technique versus cross technique in LESS hysterectomy (CCLEH study): a prospective randomized controlled trial.", "datePublished": "2022-08-20", "url": "https://questionsmedicales.fr/article/35987770", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06650-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Accidents", "item": "https://questionsmedicales.fr/mesh/D000059" }, { "@type": "ListItem", "position": 5, "name": "Prévention des accidents", "item": "https://questionsmedicales.fr/mesh/D000056" }, { "@type": "ListItem", "position": 6, "name": "Sécurité", "item": "https://questionsmedicales.fr/mesh/D012449" }, { "@type": "ListItem", "position": 7, "name": "Sécurité chimique", "item": "https://questionsmedicales.fr/mesh/D062067" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sécurité chimique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sécurité chimique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sécurité chimique", "description": "Comment évaluer l'exposition chimique ?\nQuels tests pour détecter les toxines ?\nQuels signes d'intoxication chimique ?\nComment diagnostiquer une allergie chimique ?\nQuels professionnels pour évaluer la sécurité chimique ?", "url": "https://questionsmedicales.fr/mesh/D062067?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sécurité chimique", "description": "Quels symptômes d'une exposition aiguë ?\nComment reconnaître une intoxication chronique ?\nQuels effets sur la peau ?\nQuels symptômes respiratoires possibles ?\nQuels signes neurologiques d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D062067?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sécurité chimique", "description": "Comment prévenir l'exposition chimique ?\nQuelles formations pour la sécurité chimique ?\nQuels équipements de protection individuelle ?\nComment gérer les déchets chimiques ?\nQuelles normes de sécurité à respecter ?", "url": "https://questionsmedicales.fr/mesh/D062067?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sécurité chimique", "description": "Quel traitement pour une intoxication aiguë ?\nComment traiter les brûlures chimiques ?\nQuels médicaments pour les allergies chimiques ?\nComment gérer une exposition prolongée ?\nQuels soins pour les irritations cutanées ?", "url": "https://questionsmedicales.fr/mesh/D062067?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sécurité chimique", "description": "Quelles complications d'une exposition chimique ?\nQuels risques à long terme ?\nComment l'exposition affecte-t-elle la reproduction ?\nQuels effets sur le système immunitaire ?\nQuelles maladies liées à l'exposition chimique ?", "url": "https://questionsmedicales.fr/mesh/D062067?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sécurité chimique", "description": "Quels sont les facteurs de risque d'exposition ?\nComment l'âge influence-t-il le risque ?\nQuel rôle joue la génétique ?\nQuels comportements augmentent le risque ?\nComment l'environnement affecte-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D062067?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'exposition chimique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par des tests biologiques et des analyses environnementales." } }, { "@type": "Question", "name": "Quels tests pour détecter les toxines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins, urinaires ou de tissus peuvent détecter des toxines spécifiques." } }, { "@type": "Question", "name": "Quels signes d'intoxication chimique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des nausées, des vertiges, des éruptions cutanées et des difficultés respiratoires." } }, { "@type": "Question", "name": "Comment diagnostiquer une allergie chimique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests cutanés ou des analyses sanguines spécifiques." } }, { "@type": "Question", "name": "Quels professionnels pour évaluer la sécurité chimique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les toxicologues, les hygiénistes du travail et les médecins spécialisés en médecine environnementale." } }, { "@type": "Question", "name": "Quels symptômes d'une exposition aiguë ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées, des irritations cutanées et des troubles respiratoires." } }, { "@type": "Question", "name": "Comment reconnaître une intoxication chronique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, des troubles neurologiques et des problèmes respiratoires peuvent indiquer une intoxication chronique." } }, { "@type": "Question", "name": "Quels effets sur la peau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les produits chimiques peuvent causer des irritations, des éruptions cutanées ou des brûlures." } }, { "@type": "Question", "name": "Quels symptômes respiratoires possibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la toux, l'essoufflement, et des douleurs thoraciques après exposition." } }, { "@type": "Question", "name": "Quels signes neurologiques d'exposition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des maux de tête, des vertiges, et des troubles de la mémoire peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir l'exposition chimique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection, suivre les protocoles de sécurité et éduquer le personnel." } }, { "@type": "Question", "name": "Quelles formations pour la sécurité chimique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des formations sur la manipulation sécurisée des produits chimiques et les premiers secours sont essentielles." } }, { "@type": "Question", "name": "Quels équipements de protection individuelle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Gants, masques, lunettes de protection et vêtements appropriés sont recommandés." } }, { "@type": "Question", "name": "Comment gérer les déchets chimiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les déchets doivent être triés, stockés et éliminés selon les réglementations en vigueur." } }, { "@type": "Question", "name": "Quelles normes de sécurité à respecter ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Respecter les normes OSHA et les directives locales pour la manipulation des produits chimiques." } }, { "@type": "Question", "name": "Quel traitement pour une intoxication aiguë ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des antidotes, des soins de soutien et des décontaminations." } }, { "@type": "Question", "name": "Comment traiter les brûlures chimiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Rincer immédiatement la zone touchée à l'eau et consulter un professionnel de santé." } }, { "@type": "Question", "name": "Quels médicaments pour les allergies chimiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des antihistaminiques et des corticostéroïdes peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Comment gérer une exposition prolongée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des traitements symptomatiques sont nécessaires." } }, { "@type": "Question", "name": "Quels soins pour les irritations cutanées ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des crèmes apaisantes et éviter les irritants pour favoriser la guérison." } }, { "@type": "Question", "name": "Quelles complications d'une exposition chimique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des maladies respiratoires chroniques, des cancers et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels risques à long terme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut entraîner des effets sur la santé tels que des troubles endocriniens." } }, { "@type": "Question", "name": "Comment l'exposition affecte-t-elle la reproduction ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines substances chimiques peuvent nuire à la fertilité et causer des malformations congénitales." } }, { "@type": "Question", "name": "Quels effets sur le système immunitaire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition à des produits chimiques peut affaiblir le système immunitaire et augmenter les infections." } }, { "@type": "Question", "name": "Quelles maladies liées à l'exposition chimique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies comme l'asthme, la dermatite et certains cancers peuvent être liées à l'exposition." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le travail dans des environnements industriels, l'utilisation de produits ménagers et le manque de formation." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants et les personnes âgées sont plus vulnérables aux effets des produits chimiques." } }, { "@type": "Question", "name": "Quel rôle joue la génétique ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "La susceptibilité génétique peut influencer la réaction d'un individu aux produits chimiques." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements comme le tabagisme et la consommation d'alcool peuvent augmenter les risques." } }, { "@type": "Question", "name": "Comment l'environnement affecte-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La pollution de l'air et de l'eau peut augmenter l'exposition aux produits chimiques nocifs." } } ] } ] }

Sources (10000 au total)

Ultrasound-guided paravertebral blockade reduced perioperative opioids requirement in pancreatic resection: A randomized controlled trial.

Perioperative opioid use for pain control has been found to be associated with side effects and adverse prognosis. In this study, we hypothesized that paravertebral block could reduce the consumption ... We conducted a prospective, randomized trial. Patients with resectable pancreatic cancer were randomly assigned to one of the two groups: those who received bilateral paravertebral block combined with... A total of 153 patients were enrolled in the study and 119 cases were analyzed. Compared to the control group, patients in PTB patients had significantly lower perioperative (30.81 vs. 56.17 µg), and ... Bilateral paravertebral block combined with general anesthesia reduced the perioperative consumption of opioids by 45%.... ChiCTR1800020291 (available on http://www.chictr.org.cn/)....

Pericapsular nerve group (PENG) block for hip arthroscopy: a randomized, double-blinded, placebo-controlled trial.

Arthroscopic hip surgery is associated with significant postoperative pain. Femoral nerve blocks have been shown to improve postoperative analgesia at the expense of quadriceps weakness. The pericapsu... Subjects presenting for arthroscopic hip surgery were randomized in a 1:1 ratio to either an ultrasound-guided unilateral, single-injection PENG block (PENG group) with 20 mL of 0.5% ropivacaine or a ... Sixty-eight subjects, 34 from the PENG group and 34 from the Sham group, completed the study per protocol. Analysis of the primary outcome demonstrated a mean difference in pain scores of -0.79 (95% C... This study demonstrates that a preoperative PENG block does not improve analgesia following arthroscopic hip surgery.... NCT04508504....

A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.

Efruxifermin has shown clinical efficacy in patients with non-alcoholic steatohepatitis (NASH) and F1-F3 fibrosis. The primary objective of the BALANCED Cohort C was to assess the safety and tolerabil... Patients with NASH and stage 4 fibrosis (n = 30) were randomized 2:1 to receive efruxifermin 50 mg (n = 20) or placebo (n = 10) once-weekly for 16 weeks. The primary endpoint was safety and tolerabili... Efruxifermin was safe and well-tolerated; most adverse events (AEs) were grade 1 (n = 7, 23.3%) or grade 2 (n = 19, 63.3%). The most frequent AEs were gastrointestinal, including transient, mild to mo... Efruxifermin appeared safe and well-tolerated with encouraging improvements in markers of liver injury, fibrosis, and glucose and lipid metabolism following 16 weeks of treatment, warranting confirmat... Cirrhosis resulting from non-alcoholic steatohepatitis (NASH), the progressive form of non-alcoholic fatty liver disease, represents a major unmet medical need. Currently there are no approved drugs f... NCT03976401....

Chopstick technique versus cross technique in LESS hysterectomy (CCLEH study): a prospective randomized controlled trial.

The traditional cross technique can be used to complete most laparoendoscopic single-site surgery (LESS) procedures, but some relatively precise operations, such as vaginal stump suturing, are challen... Patients who undergo total hysterectomy will be enrolled in this RCT. Stratified randomization will be performed according to uterine size (< 10 cm, 10-15cm, ≥ 15 cm). The participants will be divided... It is expected that the efficacy of the two techniques in LESS, the chopstick technique vs. the cross technique, will be compared and accumulate safety data on the new techniques will be accumulated.... ChiCTR2000040843, registered on June 16,2020 Protocol version: Version 2.0; Date: 2020.05.10....

Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.

The aim of this study was to investigate the comparative efficacy of neuromodulation technologies for overactive bladder (OAB) syndrome in adults.... A computerized search was conducted of Cochrane Library, EMBASE, MEDLINE (via PubMed), Web of Science, CNKI, Wan Fang Data, and ClinicalTrials.gov up to April 21, 2022.... The search selected clinical trials with random allocation to percutaneous tibial nerve stimulation (PTNS), transcutaneous tibial nerve stimulation (TTNS), vaginal electrical stimulation (VES), sacral... The main outcomes were the voiding diary, OAB-related quality of life, and positive response rate. The Cochrane Risk of Bias tool (RoB 2.0) was used to assess the risk of bias of each included study, ... The study included 21 randomized controlled trials involving 1433 participants, and all trials were used for the meta-analysis. In the network meta-analyses, five of six neuromodulation technologies, ... Neuromodulation technologies, including PTNS, TTNS, VES, SNM, and PS, may be effective and safe solutions for OAB syndrome in adults. Moreover, SNM is the most efficacious regimen for OAB-related qual...

Effects of side-effect risk framing strategies on COVID-19 vaccine intentions: a randomized controlled trial.

Fear over side-effects is one of the main drivers of COVID-19 vaccine hesitancy. A large literature in the behavioral and communication sciences finds that how risks are framed and presented to indivi... We conducted a pre-registered randomized controlled trial among 8998 participants in the United States and the United Kingdom to examine the effects of different ways of framing and presenting vaccine... Adding a descriptive risk label ('very low risk') next to the numerical side-effect and providing a comparison to motor-vehicle mortality increased participants' willingness to take the COVID-19 vacci... Low-cost side-effect framing strategies can meaningfully affect vaccine intentions at a population level.... Heidelberg Institute of Global Health.... German Clinical Trials Registry (#DRKS00025551)....

A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis.

To assess the efficacy and safety of infliximab versus placebo in the treatment of patients with juvenile-onset spondyloarthritis (JoSpA).... Phase III, randomized, double-blind, placebo-controlled trial of 12 weeks that included patients ≤ 18 years old with JoSpA not responding to nonsteroidal anti-inflammatory drugs, sulfasalazine, or met... We randomized 12 patients to infliximab and 14 to placebo. No significant differences were found between groups at baseline. At week 12, the mean number of active joints was 1.4 (SD 2.4) in the inflix... Infliximab is efficacious for patients with JoSpA with an inadequate response to conventional treatment. No serious adverse events with the use of infliximab were observed....